TGFB1 and cancer: It has been shown that the use of TGF-β signaling inhibitors in CRC PDX models to block the crosstalk between cancer cells and the microenvironment reduced the number of metastases, demonstrating a dependency on TGF-β signaling in stromal cells during metastasis in CRC [54].